Extended Data Fig. 1: Patient disposition.

Of 125 participants assessed for eligibility, 101 were randomly assigned to semaglutide (n = 51) or placebo (n = 50). Of these, 47 participants in the semaglutide group and 46 participants in the placebo group completed the study.